Followers | 15 |
Posts | 1617 |
Boards Moderated | 0 |
Alias Born | 01/30/2001 |
Thursday, July 24, 2014 12:23:21 AM
.
.
.
The NDA will prevent him from discussing items within the written agreement, not items pertaining to the BOD's vision. That is what is very cloudy. What do they mean by monetize? So far it looks like it means SELL SHARES.
Is the BOD looking to sell the patents or licence them?
Sell VPLM itself?
Merger VPLM?
Does the BOD have a price in mind they are willing to accept?
Does the BOD have a timeframe they are looking to sell/licence by?
Are they in active negotiations with other companies?
If so, what is the timeframe to get these negotiations ironed out?
Many things investors are kept in the dark about.
I know, I know, they do that on purpose so nobody knows their strategy all for the good of the shareholders.
Recent VPLM News
- ILUS International Inc (ILUS) Sees 557% Q1 Revenue Increase, Begins National Exchange Uplist Procedure for Subsidiaries and Company • InvestorsHub NewsWire • 06/05/2023 12:15:00 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM